The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. - PubMed - NCBI
Conclusion:
"As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required."